ResearcherYokohama City UniversityNo recent work listed
Masakatsu Numata
Matched on ORCID iD 0000-0003-0414-0046; OpenAlex author ID A5070677158. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers
Papers 7
- The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer. Co-author DOI 10.21873/invivo.11931↗
- The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuva… Co-author DOI 10.4103/jcrt.jcrt_440_18↗
- The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. Co-author DOI 10.7150/jca.28660↗
- The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy. Co-author DOI 10.21873/anticanres.12801↗
- Combining the Glasgow Prognostic Score and Serum Carbohydrate Antigen 19-9 Level Improves the Ability to Predict Early Recurrence in Resected Pancreatic Cancer… Co-author PMID 27127159↗
- The clinical significance of SWI/SNF complex in pancreatic cancer. Co-author DOI 10.3892/ijo.2012.1723↗
- The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with su… Co-author DOI 10.1016/j.ejso.2012.08.008↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Soichiro Morinaga · 7 shared papers, 2012–2020 · strength 0.45
- Paper The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer. DOI 10.21873/invivo.11931↗
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Hiroshi Tamagawa · 6 shared papers, 2012–2020 · strength 0.40
- Paper The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer. DOI 10.21873/invivo.11931↗
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Naoto Yamamoto · 5 shared papers, 2013–2020 · strength 0.37
- Paper The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer. DOI 10.21873/invivo.11931↗
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Masaaki Murakawa · 4 shared papers, 2018–2020 · strength 0.34
- Paper The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer. DOI 10.21873/invivo.11931↗
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Toru Aoyama · 4 shared papers, 2018–2020 · strength 0.34
- Paper The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer. DOI 10.21873/invivo.11931↗
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Mariko Kamiya · 3 shared papers, 2018–2020 · strength 0.25
- Paper The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer. DOI 10.21873/invivo.11931↗
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection F… DOI 10.21873/anticanres.12801↗
- Satoshi Kobayashi · 3 shared papers, 2018–2020 · strength 0.24
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Paper The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection F… DOI 10.21873/anticanres.12801↗
- Manabu Morimoto · 3 shared papers, 2018–2020 · strength 0.24
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Paper The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection F… DOI 10.21873/anticanres.12801↗
- Makoto Ueno · 3 shared papers, 2018–2020 · strength 0.24
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Paper The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection F… DOI 10.21873/anticanres.12801↗
- Takashi Oshima · 2 shared papers, 2018–2020 · strength 0.16
- Paper The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who recei… DOI 10.4103/jcrt.jcrt_440_18↗
- Paper The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection F… DOI 10.21873/anticanres.12801↗
- Yohei Miyagi · 3 shared papers, 2012–2019 · strength 0.14
- Paper The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection. DOI 10.7150/jca.28660↗
- Paper The clinical significance of SWI/SNF complex in pancreatic cancer. DOI 10.3892/ijo.2012.1723↗
- Paper The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pa… DOI 10.1016/j.ejso.2012.08.008↗
- Makoto Akaike · 3 shared papers, 2012–2016 · strength 0.12
- Paper Combining the Glasgow Prognostic Score and Serum Carbohydrate Antigen 19-9 Level Improves the Ability to Predict Early … PMID 27127159↗
- Paper The clinical significance of SWI/SNF complex in pancreatic cancer. DOI 10.3892/ijo.2012.1723↗
- Paper The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pa… DOI 10.1016/j.ejso.2012.08.008↗
- Koji Numata · 1 shared paper, 2016 · strength 0.05
- Shinichi Ohkawa · 1 shared paper, 2012 · strength 0.03
- T. Watanabe · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.